About Cardiac Resynchronization Therapy-pacemaker (CRT-P)
CRT-Ps are an advanced implantable form of conventional pacemakers. They help the heart function efficiently by monitoring its signals and coordinating with the ventricles to contract at the same time. These devices resynchronize the heart's rhythm to improve breathlessness and fatigue, and avoid dizziness and fainting in individuals.
Physicians surgically implant the CRT-P under the skin, below the collarbone. They connect the electrical leads through a blood vessel into the heart. Unlike conventional pacemakers, CRT-Ps have two leads: one placed into the right ventricle and the other in the right atrium. An extra lead is implanted on the left side of the heart to stimulate the left ventricle, assisting the heart to pump efficiently.
Technavio’s analysts forecast the global cardiac resynchronization therapy-pacemaker (CRT-P) market to grow at a CAGR of 8.17% during the period 2016-2020.
Covered in this report
The report covers the present scenario and the growth prospects of the global cardiac resynchronization therapy-pacemaker (CRT-P) market for 2016-2020. To calculate the market size, the report considers the revenue generated from the sales of CRT-Ps.
The market is divided into the following segments based on geography:
• Americas
• EMEA
• APAC
Technavio's report, Global Cardiac Resynchronization Therapy-Pacemaker (CRT-P) Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
Key vendors
• BIOTRONIK
• Boston Scientific
• LivaNova
• Medtronic
• St. Jude Medical
Market driver
• Implementation of minimally invasive procedures
• For a full, detailed list, view our report
Market challenge
• Risk of potential complications
• For a full, detailed list, view our report
Market trend
• Popularity of robot-assisted cardiac surgery
• For a full, detailed list, view our report
Key questions answered in this report
• What will the market size be in 2020 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?
You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.
PART 01: Executive summary
• Highlights
PART 02: Scope of the report
• Market overview
• Top-vendor offerings
PART 03: Market research methodology
• Research methodology
• Economic indicators
PART 04: Introduction
• Key market highlights
PART 05: Market landscape
• Market overview
• Market size and forecast
• Five forces analysis
PART 06: Cost analysis of CRT-Ps and implantation
PART 07: Geographical segmentation
• CRT-P market in Americas
• CRT-P market in EMEA
• CRT-P market in APAC
PART 08: Key leading countries
• US
• France
• UK
• Germany
PART 09: Market drivers
• Incidence of cardiovascular diseases
• Government-aided awareness programs
• Implementation of minimally invasive procedures
• Demand for CRT-Ps in APAC
PART 10: Impact of drivers
PART 11: Market challenges
• Presence of alternatives
• Lack of skilled personnel
• Risk of potential complications
• Limitations of CRT-Ps in pediatric patients
PART 12: Impact of drivers and challenges
PART 13: Market trends
• Focus on R&D and clinical trials
• Popularity of robot-assisted cardiac surgery
• Focus on leadless CRT-Ps
PART 14: Vendor landscape
• Competitive scenario
PART 15: Key vendor analysis
• BIOTRONIK
• Boston Scientific
• LivaNova
• Medtronic
• St. Jude Medical
PART 16: Appendix
• List of abbreviations
PART 17: Explore Technavio
List of Exhibits
Exhibit 01: Product offerings
Exhibit 02: Global CRT-P market 2015-2020 ($ millions)
Exhibit 03: Five forces analysis
Exhibit 04: Cost comparison of CRT-P and ICD and their implantation
Exhibit 05: Global CRT-P market segmentation by geography 2015
Exhibit 06: Global CRT-P market segmentation by geography 2020
Exhibit 07: Global CRT-P market segmentation by geography 2015-2020
Exhibit 08: CRT-P market in Americas 2015-2020 ($ millions)
Exhibit 09: CRT-P market in EMEA 2015-2020 ($ millions)
Exhibit 10: CRT-P market in APAC 2015-2020 ($ millions)
Exhibit 11: CRT-P market in US 2015-2020 ($ millions)
Exhibit 12: CRT-P market in France 2015-2020 ($ millions)
Exhibit 13: CRT-P market in UK 2015-2020 ($ millions)
Exhibit 14: CRT-P market in Germany 2015-2020 ($ millions)
Exhibit 15: Impact of drivers
Exhibit 16: Impact of drivers and challenges
Exhibit 17: BIOTRONIK: Product portfolio
Exhibit 18: BIOTRONIK: Key takeaways
Exhibit 19: Boston Scientific: Cardiac rhythm management segmentation by revenue 2015
Exhibit 20: Boston Scientific: Cardiac rhythm management segmentation by revenue 2014 and 2015 ($ millions)
Exhibit 21: Boston Scientific: Geographical segmentation of cardiac rhythm management by revenue 2015
Exhibit 22: Key takeaways: Boston Scientific
Exhibit 23: LivaNova: Product portfolio
Exhibit 24: LivaNova: Key takeaways
Exhibit 25: Medtronic: Product portfolio
Exhibit 26: Key takeaways: Medtronic
Exhibit 27: St. Jude Medical: Product portfolio
Exhibit 28: Key takeaways: St. Jude Medical
